🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to evaluate the efficacy and safety of I10E (LFB 1...
Status
Completed
Location
CHU de Bordeaux -Hôpital Haut-Lévêque
Start Date
2013-12
Trial ID
NCT01951924
This is a randomized controlled blinded superiority trial to evaluate the i...
Status
Completed
Location
The Ottawa Hospital - General Campus
Start Date
2021-06-16
Trial ID
NCT04549662
Treatments Being Tested
This pilot multicentric randomized controlled clinical trial is aimed at ev...
Status
Unknown
Location
Studio Odontoiatrico Maia Dentis
Start Date
2021-08
Trial ID
NCT04955873
The purpose of this study is to investigate the efficacy, safety of Hetromb...
Status
Completed
Location
Beijing children's hospital .Capital medical university
Start Date
2021-03-29
Trial ID
NCT04737850
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of sitagli...
Status
Completed
Location
Multiple Locations
Start Date
2008-01-15
Trial ID
NCT00541450
The goal of this clinical trial is to test how safe and effective it is to ...
Status
Recruiting
Location
Skin Wellness Dermatology
Start Date
2025-05-20
Trial ID
NCT07041489
A Phase 1b, Exploratory, Randomized, Partially Single Blinded, Placebo and ...
Status
Unknown
Location
Hanmi
Start Date
2013-12
Trial ID
NCT02059564
Concussions affect thousands of Canadians every year. Although the effects ...
Status
Recruiting
Location
Universite de Moncton
Start Date
2022-10-01
Trial ID
NCT05589064
The purpose of the study is to evaluate the efficacy of IFX-1 treatment as ...
Status
Completed
Location
Clinical Site
Start Date
2019-04-03
Trial ID
NCT03895801
Treatments Being Tested
This is a 2-Stage, Phase I/II Study to Assess the Safety, Reactogenicity, a...
Status
Recruiting
Location
Nucleus Network - Brisbane (Q Pharm)
Start Date
2025-02-24
Trial ID
NCT06680128
Treatments Being Tested